1422 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
Rank Status Study
21 Recruiting Improving Adherence Among HIV+ Rwandan Youth: A TI-CBTe Indigenous Leader Model
Condition: Human Immunodeficiency Virus
Intervention: Behavioral: Trauma-Informed Cognitive Behavioral Therapy enhanced (TI-CBTe)
22 Not yet recruiting Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South Africa
Condition: Human Immunodeficiency Virus
Interventions: Drug: cabotegravir;   Drug: Placebo
23 Not yet recruiting Clinical Evaluation of the Xpert® HIV-1 VL
Condition: Human Immunodeficiency Virus
Intervention: Device: Xpert HIV-1 VL Assay
24 Not yet recruiting ART Readiness in HIV-infected Pregnant Women
Condition: Human Immunodeficiency Virus
Interventions: Behavioral: Enhanced Adherence Package;   Other: Standard of Care
25 Not yet recruiting Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection
Condition: Hepatitis C Infection With HIV Co-Infection
Intervention: Drug: LDV/SOF
26 Not yet recruiting Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects
Condition: Asymptomatic HIV Infection
Interventions: Drug: Intravenous deferiprone;   Drug: Placebo
27 Enrolling by invitation Regular HIV Testing Among At-Risk Latino Men
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Behavioral: Social Network;   Behavioral: Comparison
28 Recruiting Safety, PK and PD Study of ABX264 in Untreated HIV Patients
Condition: Human Immunodeficiency Virus Infections
Interventions: Drug: ABX464;   Other: Placebo
29 Recruiting PRO 140 for Human Immunodeficiency Virus
Condition: HIV
Intervention: Biological: PRO 140
30 Recruiting Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection
Conditions: Anal Squamous Cell Carcinoma;   HIV Infection;   Stage 0 Anal Canal Cancer;   Stage I Anal Canal Cancer
Intervention: Procedure: Therapeutic Conventional Surgery
31 Recruiting Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy Women
Condition: Human Immunodeficiency Virus (HIV) Prophylaxis
Interventions: Drug: TDF IVR;   Drug: TDF-FTC IVR;   Drug: TDF-FTC-MVC IVR
32 Recruiting Evaluation of the Role of OCT in the Detection of HIV-associated Neurocognitive Disorder
Condition: AIDS-Related Dementia Complex
Intervention: Other: Optical Coherence Tomography
33 Recruiting Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: DTG 50 mg;   Drug: RPV 25 mg;   Drug: CAR
34 Not yet recruiting Calcium and High-dose Vitamin D Supplementation on Bone Mineral Density Among HIV-infected Children and Adolescents
Conditions: Adverse Bone Health;   HIV Infection
Interventions: Dietary Supplement: High dose vitamin D and calcium;   Dietary Supplement: Normal dose vitamin D and calcium
35 Not yet recruiting Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: DTG 50 mg;   Drug: RPV 25 mg;   Drug: CAR
36 Not yet recruiting PK Study of Rifampicin Interactions With DMPA and Efaviranz in TB
Conditions: HIV-1 Infection;   Tuberculosis
Intervention: Drug: depot medroxyprogesterone acetate
37 Not yet recruiting Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: CAB;   Drug: RIF
38 Recruiting Determine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients
Conditions: Asthma;   HIV
Intervention:
39 Recruiting A Safety and Immune Response Study of 2 Experimental HIV Vaccines
Condition: HIV Infection
Interventions: Biological: ALVAC-HIV;   Biological: Bivalent Subtype C gp120/MF59®;   Biological: ALVAC-HIV (vCP2438) Placebo;   Biological: Bivalent gp120/MF59® Placebo
40 Not yet recruiting Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects
Condition: HIV Positive
Interventions: Drug: darunavir/cobicistat;   Drug: rilpivirine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years